Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Rationale for anti-OX40 cancer immunotherapy
HTML
Details
Locations
Year:
2015
Type:
review
Source:
European Journal of Cancer
DOI:
10.1016/j.ejca.2015.08.021
Authors:
Sandrine Aspeslagh,
Sophie Postel-Vinay,
Sylvie Rusakiewicz,
Jean-Charles Soria,
Laurence Zitvogel,
Aurélien Marabelle
show all 6
Institutions:
Ghent University Hospital,
Institut Gustave Roussy,
Université Paris-Sud,
Inserm
Language:
English
Topic:
Cancer Immunotherapy and Biomarkers
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
Funder:
European Society for Medical Oncology
OpenAlex ID:
W2189381691
FWCI:
3.246
Cites:
69
Cited by:
328
Related to:
10